e-Drug3D 716 |
cas 103775-10-6 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters F 13 PERCENT Solubility SOLUBLE IN WATER |
Target TARGET ANGIOTENSIN CONVERTING ENZYME (ACE) |
DrugCentral Angiotensin-converting enzyme UNIPROT P12821 ACE |
Download SDF file | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid Formula: Calculated chemical properties: MW 497.55 NB_atoms 36 XLogP 1.25 PSA 108.573 NB_HD 1 NB_HA 9 fsp3 0.44 Lipinski(0=no;1=yes) 1 |
FDA NDA 020312 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) UNIVASC (UCB INC) APPROVAL= AP YEAR= 1995 DISCONTINUED NDA 020729 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) UNIRETIC (UCB INC) APPROVAL= AP YEAR= 1997 DISCONTINUED NDA 076204 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (TEVA) APPROVAL= AP YEAR= 2003 NDA 077536 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2006 NDA 076980 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (TEVA) APPROVAL= AP YEAR= 2007 NDA 078454 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (APOTEX INC) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 090096 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (CHARTWELL RX) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 090416 (pdf not found) INN (MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE (GLENMARK PHARMS LTD) APPROVAL= AP YEAR= 2010 NDA 090718 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (GLENMARK PHARMS) APPROVAL= AP YEAR= 2010 NDA 202150 (pdf not found) INN (HYDROCHLOROTHIAZIDE ; MOEXIPRIL HYDROCHLORIDE) MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE (HERITAGE PHARMS) APPROVAL= AP YEAR= 2014 DISCONTINUED |
Other links: |